Industry Analysis: Age Refined Limited

1. Industry Classification

Sector: SIC 86900 – Other Human Health Activities
Sub-sector positioning: Aesthetic and cosmetic health services (inferred from trading name "Age Refined" and operational profile)

Age Refined Limited operates within the UK's private aesthetic medicine and cosmetic health services market, classified under SIC 86900. This sector encompasses non-NHS health activities including aesthetic clinics, complementary therapies, and specialist wellbeing providers. The UK medical aesthetics market has experienced considerable growth over the past decade, driven by rising demand for non-surgical cosmetic procedures, but has also faced intensifying competition and regulatory scrutiny. Businesses in this space typically require modest capital investment in specialist equipment but face ongoing costs for clinical supplies, insurance, and regulatory compliance with bodies such as the Care Inspectorate (Scotland) and the General Medical Council.

Key characteristics of this sector include: - Asset-heavy operational models for clinic-based providers (treatment premises, specialist equipment) - Working capital volatility driven by stock holding (dermal fillers, pharmaceutical products) and payment timing - Regulatory burden requiring compliance with healthcare standards and, increasingly, licensing under the Scottish cosmetic procedures framework - Labour intensity with reliance on qualified practitioners

2. Relative Performance

Balance Sheet Structure – Significant Property-Heavy Position

The company's balance sheet is dominated by £519,103 in freehold land and buildings (representing 97.6% of total tangible fixed assets), indicating ownership of its Glasgow clinic premises at 22 Newton Place. This is atypical for the sector – most aesthetic health operators lease premises rather than hold them as owner-occupied assets. While this provides operational security, it creates a capital-intensive structure that depresses return on assets metrics.

Deteriorating Trajectory

The financial trajectory is concerning. Net assets have declined from a peak of £215,154 (2023) to £171,165 (2025), representing a 20.4% erosion over two years. More critically, the current ratio (current assets of £62,118 versus current liabilities of £171,092) stands at approximately 0.36:1 – well below the 1.0:1 threshold considered viable for ongoing trading. The company is technically insolvent on a current basis and relies on long-term debt facilities and the property asset to present a positive net asset position.

Cash has collapsed from £50,293 (2024) to £11,867 (2025), a reduction that suggests either significant capital expenditure, debt repayment, or operational cash burn. Trade debtors also fell dramatically from £45,974 to £6,190, which could indicate either improved collections or, more likely, reduced revenue generation.

Profitability Inference

The profit and loss reserve declined from £197,479 to £171,065, implying a loss of approximately £26,414 for the year. For an 8-employee aesthetic health business, this is a meaningful operating deficit and contrasts with sector norms where established clinics typically target 10-15% net margins.

3. Sector Trends Impact

Post-Pandemic Normalisation and Cost Pressures

The UK aesthetic health sector experienced a pronounced boom during 2021-2022 as pent-up demand for cosmetic procedures surged following pandemic lockdowns. Age Refined's financial history reflects this – net assets grew from £102,739 (2021) to £215,154 (2023). However, the sector has since normalised, with several headwinds:

• Rising input costs: Pharmaceutical and consumable costs (hyaluronic acid fillers, botulinum toxin, skincare products) have increased with broader healthcare supply chain inflation. The company's stock rising from £15,588 to £20,000 may reflect higher unit costs rather than increased volume.

• Labour cost inflation: The Scottish healthcare sector has experienced above-average wage inflation, particularly for qualified nurse practitioners and aesthetic clinicians. The reduction from 9 to 8 employees may indicate cost-driven headcount management.

• Interest rate environment: With £276,168 in long-term bank borrowings (Bank of Scotland, secured by floating charges), the company is exposed to interest rate movements. The modest reduction in long-term debt to £248,335 suggests active repayment, but servicing costs will have risen materially since 2022.

• Regulatory tightening: The Scottish Government's ongoing consultation on licensing of non-surgical cosmetic procedures creates compliance cost uncertainty. Clinics operating from owned premises (as here) face additional property compliance burdens.

• Competitive saturation: The Glasgow aesthetic market has seen significant new entrants, including large chains (SKINN, Transform) and independent practitioners, compressing pricing power for established operators.

4. Competitive Positioning

Strengths: - Freehold premises ownership provides long-term security and eliminates rental cost volatility – a genuine competitive advantage in Glasgow's commercial property market - Established trading history (incorporated 2012) suggests brand recognition and client retention capability - Consistent positive net assets throughout the period, demonstrating underlying equity strength despite recent deterioration - Director commitment – Xxxxxx Xxxxxxxxname shown to subscribers holds >75% ownership, aligning incentives with business sustainability

Weaknesses: - Liquidity crisis: The net current liabilities of £108,974 represent a serious going concern indicator. The company cannot meet its current obligations from current assets and is dependent on debt facilities and property value to remain solvent - High leverage: Total liabilities of £419,551 (current £171,092 + long-term £248,335 + provisions £3,124) against equity of £171,165 creates a debt-to-equity ratio of approximately 2.45:1 – significantly above the sector norm of 0.5-1.0:1 for established aesthetic operators - Cash depletion: With only £11,867 in cash and £6,190 in trade debtors, the company has minimal liquidity headroom. Any disruption to revenue or unexpected cost would create immediate solvency pressure - Declining revenue indicators: The collapse in trade debtors and cash, combined with the operating loss, suggests revenue contraction rather than growth - Single-director dependency: With Xxxxxx Xxxxxxxxname shown to subscribers as sole director and PSC, the business has key-person risk and limited governance oversight

Competitive Context: Within the Scottish aesthetic health market, Age Refined appears positioned as a small independent niche operator rather than a market leader. Its property asset provides differentiation from lease-dependent competitors, but the financial structure suggests the business may be asset-rich and cash-poor – a common profile for owner-operated clinics that have invested heavily in premises. The sector typically sees successful operators maintaining current ratios above 1.5:1 and debt-to-equity below 1.0:1, metrics that Age Refined currently falls well short of.

Names of the people mentioned are shown to subscribers. See subscription